Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens

被引：1
|
作者：
Caldara, Rossana [1 ]
Tomajer, Valentina [2 ]
Piemonti, Lorenzo [3 ,4 ]
机构：
[1] IRCCS Osped San Raffaele, Regenerat & Transplant Med Unit, Milan, Italy
[2] IRCCS Osped San Raffaele, Pancreas Translat & Clin Res Ctr, Pancreat Surg, Milan, Italy
[3] IRCCS Osped San Raffaele, Diabet Res Inst, Milan, Italy
[4] Univ Vita Salute San Raffaele, Milan, Italy
来源：
TRANSPLANT INTERNATIONAL | 2023年 / 36卷
关键词：
islet transplant; immunosuppression; calcineurin inhibitors; calcineurin inhibitor toxicity; tolerance induction; ISLET TRANSPLANTATION; INSULIN INDEPENDENCE; PHASE-3; TRIAL;
D O I：
10.3389/ti.2023.11565
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Improved Pulse Wave Velocity and Renal Function in Individualized Calcineurin Inhibitor Treatment by Immunomonitoring: The Randomized Controlled Calcineurin Inhibitor-Sparing Trial
    Sommerer, Claudia
    Brooke, Janina
    Bruckner, Thomas
    Schaier, Matthias
    Morath, Christian
    Meuer, Stefan
    Zeier, Martin
    Giese, Thomas
    TRANSPLANTATION, 2018, 102 (03) : 510 - 520
  • [22] The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
    Claudia Sommerer
    Matthias Schaier
    Christian Morath
    Vedat Schwenger
    Geraldine Rauch
    Thomas Giese
    Martin Zeier
    Trials, 15
  • [23] Calcineurin inhibitor-sparing immunosuppressive protocols: PSGL-Ig plus RAPA/CsA prevents donor brain death induced injury to renal allografts
    Gasser, M
    Waaga-Gasser, AM
    Holthe, JEKV
    Lenhard, MS
    Shaw, GD
    Hancock, WW
    Tilney, NL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 359A - 359A
  • [24] Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence
    Camilleri, Brian
    Bridson, Julie M.
    Halawa, Ahmed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (05) : 471 - 483
  • [25] Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens
    Smith, KY
    Steffens, CM
    Truckenbrod, A
    Landay, A
    Al-Harthi, L
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 544 - 545
  • [26] The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
    Sommerer, Claudia
    Schaier, Matthias
    Morath, Christian
    Schwenger, Vedat
    Rauch, Geraldine
    Giese, Thomas
    Zeier, Martin
    TRIALS, 2014, 15
  • [27] Considerations in the choice of protease inhibitor-sparing regimens in initial therapy for HIV-1 infection
    Moyle, GJ
    CURRENT OPINION IN INFECTIOUS DISEASES, 2000, 13 (01) : 19 - 25
  • [28] Meta-Analysis of Calcineurin-Inhibitor-Sparing Regimens in Kidney Transplantation
    Sharif, Adnan
    Shabir, Shazia
    Chand, Sourabh
    Cockwell, Paul
    Ball, Simon
    Borrows, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (11): : 2107 - 2118
  • [29] Rabbit ATG induction as a calcineurin inhibitor-sparing protocol in steroid-free liver transplantation.
    Eason, James D.
    Saharia, Ashish
    Vera, Santiao
    Nezakatgoo, Nosrat
    Nair, Satheesh
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 313 - 313
  • [30] Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
    Haubrich, Richard H.
    Riddler, Sharon A.
    DiRienzo, A. Gregory
    Komarow, Lauren
    Powderly, William G.
    Klingman, Karin
    Garren, Kevin W.
    Butcher, David L.
    Rooney, James F.
    Haas, David W.
    Mellors, John W.
    Havliri, Diane V.
    AIDS, 2009, 23 (09) : 1109 - 1118
12345